A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. [electronic resource]
Producer: 20150730Description: 848-52 p. digitalISSN:- 1468-2079
- Adult
- Angiogenesis Inhibitors -- therapeutic use
- Blood-Retinal Barrier
- Capillary Permeability
- Central Serous Chorioretinopathy -- diagnosis
- Chronic Disease
- Fluorescein Angiography
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Pilot Projects
- Prospective Studies
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Subretinal Fluid
- Tomography, Optical Coherence
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.